|
|
|
| Abbott Laboratories v. Sandoz, Inc. |
 |
Abbott Laboratories
|
|
|
|
| Our attorneys secured a settlement for client Abbott Laboratories after a five-year patent litigation battle brought against Sandoz, Inc. involving Abbott's branded antibiotic known as BIAXIN XL®. Abbott sued Sandoz for patent infringement in 2005 when Sandoz sought to market a generic version. Abbott won a preliminary injunction against Sandoz, which was affirmed on appeal by the Federal Circuit, and then won partial summary judgment. Abbott prepared to take the remainder of the case to trial, seeking $68 million in damages for an aborted 2006 product launch by Sandoz. Only two weeks before trial, the judge issued a series of favorable rulings on Abbott's evidentiary motions, resulting in Sandoz agreeing to a confidential last-minute settlement. |
|
|
Select A Region
Search for an attorney.
